Vext Science Balance Sheet Health

Financial Health criteria checks 2/6

Vext Science has a total shareholder equity of $71.0M and total debt of $38.8M, which brings its debt-to-equity ratio to 54.6%. Its total assets and total liabilities are $118.2M and $47.3M respectively. Vext Science's EBIT is $772.1K making its interest coverage ratio 0.2. It has cash and short-term investments of $3.6M.

Key information

54.6%

Debt to equity ratio

US$38.77m

Debt

Interest coverage ratio0.2x
CashUS$3.63m
EquityUS$70.96m
Total liabilitiesUS$47.26m
Total assetsUS$118.22m

Recent financial health updates

Recent updates

There Is A Reason Vext Science, Inc.'s (CSE:VEXT) Price Is Undemanding

Jan 16
There Is A Reason Vext Science, Inc.'s (CSE:VEXT) Price Is Undemanding

Is Now The Time To Put Vext Science (CSE:VEXT) On Your Watchlist?

Sep 29
Is Now The Time To Put Vext Science (CSE:VEXT) On Your Watchlist?

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Aug 16
Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Jan 17
Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Shareholders May Be More Conservative With Vext Science, Inc.'s (CSE:VEXT) CEO Compensation For Now

Dec 09
Shareholders May Be More Conservative With Vext Science, Inc.'s (CSE:VEXT) CEO Compensation For Now

We Think Vext Science (CSE:VEXT) Can Stay On Top Of Its Debt

Sep 29
We Think Vext Science (CSE:VEXT) Can Stay On Top Of Its Debt

Vext Science (CSE:VEXT) Seems To Use Debt Quite Sensibly

Apr 29
Vext Science (CSE:VEXT) Seems To Use Debt Quite Sensibly

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Nov 15
Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Is Vext Science (CSE:VEXT) A Risky Investment?

Jul 15
Is Vext Science (CSE:VEXT) A Risky Investment?

Weak Statutory Earnings May Not Tell The Whole Story For Vext Science (CSE:VEXT)

Apr 25
Weak Statutory Earnings May Not Tell The Whole Story For Vext Science (CSE:VEXT)

Based On Its ROE, Is Vext Science, Inc. (CSE:VEXT) A High Quality Stock?

Jan 15
Based On Its ROE, Is Vext Science, Inc. (CSE:VEXT) A High Quality Stock?

Financial Position Analysis

Short Term Liabilities: VEXT's short term assets ($37.6M) exceed its short term liabilities ($10.4M).

Long Term Liabilities: VEXT's short term assets ($37.6M) exceed its long term liabilities ($36.9M).


Debt to Equity History and Analysis

Debt Level: VEXT's net debt to equity ratio (49.5%) is considered high.

Reducing Debt: VEXT's debt to equity ratio has increased from 8.6% to 54.6% over the past 5 years.

Debt Coverage: VEXT's debt is not well covered by operating cash flow (17.2%).

Interest Coverage: VEXT's interest payments on its debt are not well covered by EBIT (0.2x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.